Casein Kinase 1α Antibody (Rabbit mAb) [B16K10]

CatNo: F5207

    Application: Reactivity:
    • Lane 1: Mouse brain, Lane 2: Mouse kidney, Lane 3: Mouse spleen, Lane 4: Rat brain
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:30
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    39 kDa 36 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human fetal brain tissue; Human fetal kidney tissue; Human fetal spleen tissue; Human skin tissue; Mouse skin tissue; Rat skin tissue; Mouse brain tissue; Rat spleen tissue; HEK-293T cells; HeLa cells; MCF7 cells; NIH/3T3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Casein Kinase 1α Antibody (Rabbit mAb) [B16K10] detects endogenous levels of total Casein Kinase 1α protein.
    タンパク質の局在
    細胞突起、セントロメア、染色体、細胞質、細胞骨格、キネトコア、細胞核
    Uniprot ID
    P48729
    Clone
    B16K10
    Synonym(s)
    Casein kinase I isoform alpha, CKI-alpha, CK1, CSNK1A1
    Background
    Casein kinase 1α (CK1α) is a ubiquitously expressed serine/threonine kinase of the CK1 family that preferentially phosphorylates acidic or pre-phosphorylated substrates and serves as a central regulator of multiple signaling pathways, including Wnt/β‑catenin, circadian, mTOR and inflammasome networks. The kinase comprises a conserved catalytic domain with an N‑terminal lobe that binds ATP and a C‑terminal lobe that engages substrates, flanked by short regulatory regions that influence subcellular localization and interaction with scaffolding proteins at membranes, cytoskeleton and kinetochores. In the Wnt pathway, CK1α phosphorylates β‑catenin at Ser45 within the N‑terminal degron, priming it for subsequent GSK3β phosphorylation and recognition by the β‑TrCP E3 ligase, thereby promoting β‑catenin ubiquitination and proteasomal degradation and acting as an established negative regulator of canonical Wnt signaling in development and Wnt-driven cancers. CK1α also phosphorylates components of the circadian clock, such as PER1 and PER2, modulating their stability and nuclear localization and contributing to the timing of transcriptional oscillations that underlie circadian rhythm control. In nutrient sensing, CK1α functions as a positive regulator of mTORC1 and mTORC2: it phosphorylates the mTOR inhibitor DEPTOR, marking it for ubiquitination and degradation, which relieves inhibition of mTOR complexes and enhances downstream signaling to S6K and Akt in response to amino acids and growth factors, integrating CK1α into control of cell growth, metabolism and survival. In innate immunity, CK1α phosphorylates NLRP3 on defined serine residues, and this modification inhibits assembly of the NLRP3 inflammasome, reducing caspase‑1 activation and IL‑1β production and positioning CK1α as a brake on pyroptotic and inflammatory responses; small-molecule modulators that enhance CK1α phosphorylation of NLRP3 can suppress inflammasome-driven pathology. CK1α also contributes to chromosome segregation and cytoskeletal regulation: it localizes to kinetochores and spindle structures and has been implicated in controlling kinetochore–microtubule attachments during mitosis, and in epithelial cells, CK1α-mediated keratin cytoskeleton disassembly supports migration and wound closure, linking its kinase activity to cell division and motility. CK1α loss or inhibition can stabilize β‑catenin and contribute to Wnt-addicted tumor growth, while overactive CK1α may enhance mTOR signaling in metabolic disease; conversely, pharmacologic CK1α activation is being explored to dampen NLRP3 inflammasome activity and as a strategy to target Wnt-driven cancers such as colorectal and prostate cancer by reinforcing β‑catenin turnover.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください